Fungal Toenail Onychomycosis Treatment 2026 | DPM

Clinical Type	Pattern	Causative Organism	Appearance	Nail Involved
Distal Lateral Subungual (DLSO) — Most Common	Begins at distal/lateral nail edge; spreads proximally	Trichophyton rubrum (90%)	Yellow-white discoloration; hyperkeratosis; onycholysis	Hallux most common; multiple nails in advanced disease
White Superficial Onychomycosis (WSO)	White chalky patches on nail surface; superficial only	T. mentagrophytes; Fusarium spp.	White opaque islands on nail plate surface; friable	Any toenail; easier to treat (superficial)
Proximal Subungual (PSO)	Begins at proximal nail fold (cuticle); spreads distally	T. rubrum; Fusarium; immunocompromised patients	White spot at proximal nail; nail plate intact early	Consider HIV testing if present in immunocompetent adult
Total Dystrophic Onychomycosis (TDO)	End-stage; entire nail plate destroyed	Candida or dermatophytes; often mixed	Crumbling, thickened, completely opaque nail; pain with pressure	Multiple nails; systemic antifungal usually required
Candidal Onychomycosis	Periungual inflammation + nail involvement	Candida albicans	Paronychia; nail thickening; white-yellow discoloration	Fingernails more than toenails; wet-work occupations

Treatment	Mechanism	Mycologic Cure Rate	Clinical Cure Rate	Best Candidate
Topical Efinaconazole 10% (Jublia)	Azole antifungal penetrates nail plate; applied daily	54–56% at 52 weeks	15–18% complete cure	Mild-moderate DLSO; <50% nail involvement; hepatic concerns preclude oral
Topical Tavaborole 5% (Kerydin)	Boron-based antifungal; unique nail penetration	31–35%	6–9% complete cure	Mild DLSO; preferred when drug interactions limit oral options
Oral Terbinafine (Lamisil)	Allylamine; kills dermatophytes; accumulates in nail	70–80% mycologic cure	38–55% clinical cure	Moderate-severe DLSO; hallux involvement; first-line oral for dermatophyte
Oral Itraconazole (Sporanox)	Triazole; broad spectrum including Candida and molds	54–63%	14–20% complete cure	Non-dermatophyte mold or Candida onychomycosis; terbinafine failure
Laser Therapy (Nd:YAG 1064nm)	Photothermal effect kills fungal hyphae without systemic exposure	30–65% (variable; no standardized protocol)	Variable	Patients who cannot tolerate oral antifungals; adjunct to topical
Nail Avulsion + Antifungal	Mechanical removal of infected nail plate increases topical penetration	Enhanced when combined with topical or oral agent	Higher cure rates than topical alone	Severely infected, painful, or thickened nails; facilitates topical access

Fungal toenail infection—medically termed onychomycosis—affects approximately 10% of the general population and up to 50% of adults over age 70. Despite its prevalence, onychomycosis is frequently undertreated, either because patients assume nothing can be done or because they’ve tried over-the-counter products with disappointing results. Effective prescription treatment exists and works—but requires understanding why treatment takes months and how to prevent recurrence.

What Causes Fungal Toenail Infection?

Approximately 90% of onychomycosis cases are caused by dermatophytes—fungi that feed on keratin (the protein in nails and skin). Trichophyton rubrum is the single most common causative organism, responsible for roughly 70% of cases. Candida (yeast) species cause 5–10% of cases, primarily in fingernails. Non-dermatophyte molds (Scopulariopsis, Fusarium) account for the remainder and may be resistant to standard antifungal drugs used for dermatophytes.

The fungus enters through the nail’s free edge or nail folds—often gaining access through micro-trauma, adjacent athlete’s foot, or nail damage—and thrives in the warm, moist environment beneath the nail plate. This protected environment is precisely why topical over-the-counter products fail: they cannot penetrate the nail plate barrier at therapeutic concentrations.

Recognizing Onychomycosis

Classic onychomycosis findings include progressive nail thickening; yellow, brown, or white discoloration; crumbling or brittleness at the free edge; separation of the nail from the nail bed (onycholysis); and accumulation of white-yellowish debris beneath the nail plate. The most common pattern—distal-lateral subungual onychomycosis (DLSO)—begins at the nail’s free edge and spreads proximally toward the cuticle over months to years.

Nail thickening and discoloration have multiple causes besides fungal infection—including psoriatic nail disease, nail trauma, and lichen planus. For this reason, Dr. Biernacki recommends laboratory confirmation before prescribing systemic antifungal therapy. Options include KOH preparation (rapid in-office microscopy), fungal culture (identifies the specific organism and allows sensitivity testing), and PAS nail biopsy (most sensitive method at 80–90%).

Most Effective Treatment: Oral Terbinafine

Oral terbinafine (Lamisil) achieves mycological cure in 70–80% of cases—making it the gold standard for dermatophyte onychomycosis. The standard course is 250mg daily for 12 weeks. Terbinafine accumulates in the nail plate and continues exerting antifungal activity for months after the treatment course ends. However, visible nail clearance requires the infected nail to physically grow out—a process that takes 9–12 months for the hallux (big toe nail).

The primary safety consideration for terbinafine is rare hepatotoxicity. Baseline liver function tests are standard in patients with hepatic risk factors before initiating therapy. The medication also interacts with certain antidepressants and anticoagulants—Dr. Biernacki reviews each patient’s medication list before prescribing. Itraconazole is an alternative for patients who cannot take terbinafine.

Prescription Topical Antifungals

For patients who cannot take or prefer not to take oral antifungals, prescription topical agents offer meaningful improvement over OTC products. Efinaconazole 10% solution (Jublia) achieves complete cure rates of approximately 15–18% when applied daily for 48–52 weeks. Tavaborole 5% solution (Kerydin) has similar efficacy. Both are significantly better than OTC antifungals (miconazole, clotrimazole) which penetrate the nail plate poorly and have very low efficacy for established infection.

Laser Therapy for Fungal Toenails

Nd:YAG 1064nm laser devices are FDA-cleared for temporary increase of clear nail in onychomycosis. Laser energy damages fungal cell membranes through heat generation. Multiple sessions (3–4) are typically required. Clinical evidence shows laser is less effective than oral terbinafine for complete mycological cure but represents a valid option for patients who cannot take systemic antifungals.

Preventing Recurrence

Recurrence after successful treatment occurs in 20–50% of patients within 3 years. Prevention is essential: treat concurrent athlete’s foot aggressively; use antifungal powder in shoes daily; wear moisture-wicking socks; use footwear in communal wet areas; replace old footwear (which harbors spores); and apply maintenance topical antifungal monthly after achieving clinical cure. Dr. Biernacki reviews personalized prevention strategies with every successfully treated patient.

Dr. Tom's Product Recommendations

Frequently Asked Questions

How long does treatment take to work?

Most patients see improvement in 4-8 weeks with consistent conservative care. Persistent symptoms after 8 weeks need imaging and escalation.

When is surgery needed?

Surgery is reserved for cases that fail 3-6 months of conservative care, structural deformities, or fractures requiring stabilization.

Is this covered by insurance?

Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Custom orthotics often require diabetic or post-surgical justification.

Visit Balance Foot & Ankle — Same-Day Appointments Available

Our podiatry team serves patients throughout Michigan including Howell, Brighton, and Bloomfield Hills. If you’re dealing with heel pain, ingrown toenails, or a foot injury, we have same-day appointment availability.